Paper Details

  1. Home
  2. Paper Details

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Author: CatesChristopher J, PoolePhillippa, WelshEmma J

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

The relative efficacy and safety of combined inhalers and tiotropium remains uncertain. Further large, long-term randomised controlled trials are required, including adequate follow-up of all participants randomised.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Combination therapy (inhaled corticosteroids and long-acting beta2-agonists) and tiotropium are both used in the treatment of chronic obstructive pulmonary disease (COPD). There is uncertainty about the relative benefits and harms of these treatments. OBJECTIVES: To compare the relative...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD007891.pub3

データ提供：米国国立医学図書館（NLM）

Inhaled Therapies for COPD: Comparing Combination Therapy and Tiotropium

Chronic obstructive pulmonary disease (COPD) is a chronic lung disease characterized by airflow limitation and inflammation. This research compares the effectiveness and safety of two commonly used inhaled therapies for COPD: combination therapy (inhaled corticosteroids and long-acting beta2-agonists) and tiotropium. The researchers conducted a systematic review and meta-analysis of randomized controlled trials, evaluating the relative benefits and harms of these treatments in patients with COPD.

Inhaled Therapies for COPD: A Detailed Comparison

This research provides a comprehensive and insightful comparison of combination therapy and tiotropium for COPD. While the study found no significant difference in the incidence of exacerbations, it highlighted a potential increase in the risk of pneumonia with combination therapy. The researchers underscore the importance of weighing the benefits and risks of each treatment option based on individual patient characteristics.

Optimizing COPD Management: Tailoring Treatment to Individual Needs

This research emphasizes the importance of personalized medicine in COPD management. It highlights the need to carefully consider individual patient characteristics, including risk factors, medication history, and symptom profile, to tailor treatment plans and minimize potential adverse effects.

Dr. Camel's Conclusion

This research is a reminder that the world of COPD treatment is constantly evolving. Just as a camel navigates the desert, seeking out the best routes to reach its destination, researchers are continually exploring new and better ways to manage this complex disease.

Date :
  1. Date Completed 2013-11-19
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

23728670

DOI: Digital Object Identifier

10.1002/14651858.CD007891.pub3

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.